We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Low Vitamin D Levels May Harm Heart Health

By LabMedica International staff writers
Posted on 23 Nov 2015
Print article
Image: Radiograph of a child suffering a deficiency of vitamin D and has manifested symptoms of the disease Nutritional Rickets (Photo courtesy of Dr. Michael L. Richardson, MD).
Image: Radiograph of a child suffering a deficiency of vitamin D and has manifested symptoms of the disease Nutritional Rickets (Photo courtesy of Dr. Michael L. Richardson, MD).
Vitamin D is important for bone health, promoting calcium absorption, but studies have increasingly suggested the vitamin may also play an important role in heart health, linking vitamin D deficiency to increased risk for high blood pressure, heart attack and heart disease.

Individuals who do not get enough vitamin D through dietary sources including oily fish, eggs, and supplements or sun exposure often have vitamin D deficiency as when the levels of the vitamin in the body are too low, which is determined by measuring levels of 25-hydroxyvitamin D (25-OHD) in the blood.

Scientists at the Intermountain Medical Center Heart Institute (Salt Lake City, UT, USA) assessed how vitamin D levels affected the health of more than 230,000 patients who were on their database. The team allocated each patient into one of four groups dependent on their 25-OHD levels: less than 15 ng/mL, 15–29 ng/mL, 30–44 ng/mL, and more than 45 ng/mL. Over the next three years, they monitored the patients for any incidence of major cardiac events, including coronary heart disease, heart attack, stroke and heart failure, as well as incidence of kidney failure and death.

The investigators found that patients whose 25-OHD levels were less than 15 ng/mL were 35% more likely to experience a cardiovascular event in the subsequent three years than participants in the other three groups. The risk for cardiovascular events was the same for participants whose 25-OHD levels were 15–29 ng/mL, 30–44 ng/mL, or more than 45 ng/mL, according to the results. Accordingly, these findings indicate that if a person's 25-OHD levels are 15–29 ng/mL or above, they should not be concerned about the effect their vitamin D levels may have on their heart, and vitamin D supplementation is unlikely to improve heart health any further.

J. Brent Muhlestein, MD, the lead author of the study, said, “Although vitamin D levels above 30 were traditionally considered to be normal, more recently, some studies have proposed that anything above 15 was a safe level. But the numbers had not been backed up with any studies until now. Even if any level above 15 is safe, one out of 10 people still have vitamin D levels lower than that. This equates to a very large percentage of our population. The best way to determine one’s vitamin D level is by getting a blood test.” The study was presented on November 9, 2015, at the American Heart Association's Scientific Sessions held Orlando, FL, USA).

Related Links:

Intermountain Medical Center Heart Institute 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.